Emergent BioSolutions To Release Second Quarter 2013 Financial Results And Conduct A Conference Call On August 5, 2013

Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will report financial results for the second quarter 2013 on Monday, August 5, 2013, after market close.

Company management will host a conference call at 5:00 pm Eastern on August 5, 2013 to discuss the financial results for the second quarter of 2013, recent business developments, revenue guidance for the third quarter of 2013 and revenue and net income guidance for full year 2013. The conference call will be accessible by dialing 888/713-4217 or 617/213-4869 (international) and providing passcode 80425830. A webcast of the conference call will be accessible from the company’s website at www.emergentbiosolutions.com, under “Investors.”

Emergent BioSolutions is offering call participants a pre-registration option that expedites access to the call and minimizes hold times. Pre-registrants will be issued a pin number to be used when dialing into the live call which will provide quick access to the conference call by bypassing the operator upon connection. Pre-registration, while not mandatory, can be accessed using the following website: https://www.theconferencingservice.com/prereg/key.process?key=PNN4JE37W.

A replay of the conference call will be accessible, approximately two hours following the conclusion of the call, by dialing 888/286-8010 or 617/801-6888 and using the passcode 43500766. The replay will be available through August 12, 2013. The webcast will be archived on the company’s website, www.emergentbiosolutions.com, under “ Investors.”

About Emergent BioSolutions Inc.

Emergent BioSolutions is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about us may be found at www.emergentbiosolutions.com.

Follow us on twitter: @emergentbiosolu.

Copyright Business Wire 2010

If you liked this article you might like

Biotech movers: Ionis Drops After GSK Bows Out of Partnership

Emergent BioSolutions (EBS) Highlighted As Weak On High Volume

New Lifetime High For Emergent BioSolutions (EBS)

New Lifetime High Reached By Emergent BioSolutions (EBS)

New Lifetime High Reached: Emergent BioSolutions (EBS)